Colistin Sulfate Chiral Stationary Phase for the Enantioselective Separation of Pharmaceuticals Using Organic Polymer Monolithic Capillary Chromatography by Fouad, Ali et al.
molecules
Article
Colistin Sulfate Chiral Stationary Phase for the
Enantioselective Separation of Pharmaceuticals
Using Organic Polymer Monolithic Capillary
Chromatography †
Ali Fouad 1,2, Montaser Sh. A. Shaykoon 2 , Samy M. Ibrahim 3, Sobhy M. El-Adl 3
and Ashraf Ghanem 1,*
1 Chirality Program, Faculty of Science and Technology, University of Canberra,
Canberra, ACT 2601, Australia; alifouad247@gmail.com
2 Pharmaceutical Chemistry Department, Faculty of Pharmacy, Al-Azhar University, Assiut 71524, Egypt;
monoceutical@yahoo.com
3 Pharmaceutical Chemistry Department, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt;
dr-samy2010@hotmail.com (S.M.I.); sobhyeladl@yahoo.com (S.M.E.-A.)
* Correspondence: ashraf.ghanem@canberra.edu.au; Tel.: +61-(02)-6201-2089 or 0429319993;
Fax: +61-(02)-6201-2328
† The article is dedicated to Prof. Frantisek Svec on the occasion of his 75th birthday.
Academic Editors: Maria Elizabeth Tiritan, Madalena Pinto and Carla Sofia Garcia Fernandes
Received: 16 January 2019; Accepted: 21 February 2019; Published: 26 February 2019


Abstract: A new functionalized polymer monolithic capillary with a macrocyclic antibiotic, namely
colistin sulfate, as chiral selector was prepared via the copolymerization of binary monomer
mixtures consisting of glycidyl methacrylate (GMA) and ethylene glycol dimethacrylate (EGDMA) in
porogenic solvents namely 1-propanol and 1,4-butanediol, in the presence of azobisiso-butyronitrile
(AIBN) as initiator and colistin sulfate. The prepared capillaries were investigated for the
enantioselective nano-LC separation of a group of racemic pharmaceuticals, namely, α- and
β-blockers, anti-inflammatory drugs, antifungal drugs, norepinephrine-dopamine reuptake inhibitors,
catecholamines, sedative hypnotics, antihistaminics, anticancer drugs, and antiarrhythmic drugs.
Acceptable separation was achieved for many drugs using reversed phase chromatographic
conditions with no separation achieved under normal phase conditions. Colistin sulfate appears to be
useful addition to the available macrocyclic antibiotic chiral phases used in liquid chromatography.
Keywords: colistin sulfate; enantioselective; encapsulation; capillary chromatography; monolith;
organic polymer
1. Introduction
Most of the drugs currently in use are worldwide marketed as racemates. Enantiomers can exhibit
different activities in biological systems, in particular, their pharmacology, toxicology, pharmacokinetics
and metabolism. Therefore, it is important to separate single enantiomers to limit side effects that may
arise from unwanted enantiomers [1–3]. To access enantiomerically pure compounds, enantioselective
chromatographic techniques have been considered as the most feasible method compared to other
more expensive and time-consuming approaches [4–10]. Among these techniques, High Performance
Liquid Chromatography (HPLC) is the most widely used technique in enantiomer separation [11–13].
In HPLC, a chiral selector is required to form a Chiral Stationary Phase (CSP), the main driver for
the chiral separation. The CSP is normally bound, immobilized adsorbed or otherwise attached to an
appropriate support. The enantiomers are then resolved by the formation of temporary diastereomeric
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complexes between the analyte and the CSP. The stationary phase support plays a very important role
in any research investigation in this field [14–16].
Because of their advantages, the use of monoliths as stationary phases for HPLC represents
a promising alternative to particle packed columns for CEC, conventional HPLC columns and
nano-HPLC capillaries [17–21]. The preparation of organic polymer monolithic stationary phases
via surface modification with a suitable precursor followed by the polymerization process results
in increased stability of the monolith and affords greater adherence to the confining wall [22–28].
Many CSPs have been previously reported attached to monolithic support for chiral separation,
especially in enantioselective capillary chromatography [29–31]. However, only a few were macrocyclic
antibiotics [32].
Natural macrocyclic antibiotic materials play a very important role in chiral separation as useful
CSPs. In general, the macrocyclic antibiotics most widely used as chiral selectors are vancomycin,
vancomycin aglycon, norvancomycin, teicoplanin, and teicoplanin aglycon, ristocetin A, thiostrepton,
rifamycin, kanamycin, streptomycin, fradiomycin, eremomycin and avoparcin [33]. The unique
features of these chiral selectors include different chiral centers, inclusion cavities, phenyl rings, several
hydrogen donor and acceptor sites, sugar moieties, and other groups which are the main drivers for
their good chiral recognition abilities in different chromatographic modes. The chiral recognition
mechanism in most of these antibiotics chiral selectors relies heavily on complexation, hydrogen
bonding, inclusion complex formation, dipole interactions, steric interactions, and anionic and cationic
binding. These chiral selectors have been employed for the enantiomeric resolution of a variety of
racemates in HPLC, CEC, and CE [34–37]. Furthermore, a few were previously used in preparation of
chiral monolithic columns for the enantioselective separation of racemic pharmaceuticals [38]. Colistin
sulfate represents a new addition to the macrocyclic antibiotic family enabling its multi-chirality
sites and functional groups to provide chromatographic interactions with racemic analytes [38].
Furthermore, the encapsulation of a macrocyclic antibiotic in an organic polymer monolith in capillary
HPLC hasn’t been previously reported. The ease of in situ preparation in capillaries or narrow channels
of microfluidic devices render these ideal stationary phases for microscale separation formats [39].
Here we introduce a new chiral macrocyclic antibiotic, namely colistin sulfate, encapsulated in
organic polymer monolithic capillary for the enantioselective nano-liquid chromatographic separation
of a set of racemic pharmaceuticals.
2. Results
2.1. Preparation and Characterization of Polymer Monoliths
The use of macrocyclic antibiotics in chiral separation was previously reported in both
conventional HPLC and CEC. In particular, macrocyclic antibiotic-based silica monolithic columns
were previously studied [32,38,40]. However, the macrocyclic antibiotics were immobilized on the
activated monoliths by a tedious reductive amination process [32]. No work was previously reported
on the polymer monolithic antibiotic-based CSP in capillary liquid chromatography. Here we report
the first use of colistin sulfate as a macrocyclic antibiotic chiral selector entrapped in organic polymer
monolith for enantioselective capillary LC (Figure 1). The miscibility and solubility of colistin sulfate
was tested in porogenic solvents used in monolith preparation, namely 1,4-butanediol, ethanol and
n-propanol. When 1,4-butanediol was used in the polymerization mixture, a highly homogeneous
solution occurred, however, better solubility was achieved when used in combination with 1-propanol
as porogenic solvent.
Colistin sulfate-based polymer monolithic column (C1) was prepared via in situ copolymerization
of colistin sulfate with monomers (40%) (GMA (20%) as a functional monomer and EGDMA (20%)
as a cross linker) in the presence of a ternary porogenic system composed of 1-propanol (48%),
1,4-butanediol (6%) and chiral selector (6%). The ratio of the monomers to the porogens was fixed at
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40:60 w/w, respectively; this was selected to provide columns with a good balance of permeability,
surface area and mechanical stability.
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igure 1. Chemical structure of colistin sulfate (A) and teicoplanin (B).
Scanning Electron icroscopy (SEM) and Surface Properties of the Monoliths
Sca i g electron microscopy (SEM) photos were taken to study the morphology of the prepared
monolith. C lumn 1 showed a porous structure with interco necti g channels allowing the flow
of mobile phase with reduced column ba k-pressure (Figure 2). The textural surface properties of
the monolithic columns, including the specific surface area and th pore structure, were previously
calculated by o r group. The pore siz distribution was determin d from the adsorption isotherms
using the Barrett–Joyner–Halenda (BJH) method. Specific surface are (SBET) was calculated
using multi-point adsorption data from a linear segment of the N2 adsorption isotherms using the
Brunauer–Emmett–Teller (BET) theory [41]. The monolithic column previously prepared using similar
procedure and demonstrated good enantioseparation exhibited surface area of 28.67 m2/g, pore size
of 169.2 nm and total pore volume of 0.12 cm3/g.
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Figure 2. SE of column C1 at 1200× and 25,000× (left and right, respectively) shows small
micro-globules with rough surface.
Elemental analysis was used to determine the nitrogen (1.9 and 2.68 % w/w) and sulfur (0 and
0.4% w/w) content in the C1 column and blank column (G column), respectively. The blank column
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(G column) was prepared using the same polymerization mixture with addition of water instead of
colistin sulfate. The measured the nitrogen contents were 1.9 and 2.68 % w/w and the measured sulfur
contents were 0 and 0.4% w/w in the C1 column and blank column (G column), respectively. Elemental
analysis was conducted to ensure the relevance of the presence of colistin sulfate in the prepared C1
column. These results confirm the presence of the chiral selector in the prepared C1 column.
2.2. Enantioseparation of Different Classes of Pharmaceutical Racemates
The colistin sulfate-based polymer monolithic capillary column was prepared as described
above and investigated for the nano-LC enantioseparation of a set of different classes of racemic
pharmaceuticals, namely: β-blockers, α-blockers, anti-inflammatory drugs, antifungal drugs,
norepinephrine-dopamine reuptake inhibitors, catecholamines, sedative hypnotics, antihistamines,
antibacterial drugs, anticancer drugs and antiarrhythmic drugs. Although reversed phase
enantio-selective LC examples are limited, macrocyclic antibiotics were previously used in
enantioseparation chromatography under reversed phase chromatographic mode [34,36–38,42–45].
The initial mobile phase selected for the enantioseparation separation of racemates 1–37 (Figure 3) was
a binary mixture of methanol/water screened from 95:5 to 5:95 v/v at 1 mL/min flow rate at fixed UV
detection 219 nm with eleven compounds separated (Rs ≥ 1) (Table 1). For examples, in MeOH/H2O
80:20 v/v, only ibuprofen (7) was separated, while in MeOH/H2O 40:60, indoprofen (10), hexaconazole
(15) and miconazole (16) were separated. In MeOH/H2O 10:90 v/v, aminoglutethimide (22), tyrosine
(29) and O-methoxymandelic acid (34) were also separated. The addition of an additive, namely
triethylamine (TEA) 1% v/v in 10:90, resulted in the separation of acebutolol (4) normetanephrine
(21), propafenone (26), tyrosine (29) and 4-hydroxy-3-methoxymandelic acid (35) (Figure 4), while
non-acceptable separations were achieved by addition of the acidic additive namely trifluoroacetic
acid (TFA). In an attempt to use normal phase namely n-hexane/2-propanol mixture ranging from
10–90% (v/v) resulted in resolution less than 1. All chromatographic data are summarized in Table 1.
Table 1. Chromatographic data, separation and resolution factors for the significantly resolved
compounds, using reversed mobile phases, flow rate: 1 µL/min.
Column C1 (Colistin Sulfate)
Phase Mobile Phase Drug Rt1 (min) Rt2 (min)
Separation
Factor (α)
Resolution
(Rs)
Reversed
Phase
Methanol:water
80:20 Ibuprofen (7) 23.3 38.9 1.7 1.02
Methanol:water
40:60
Indoprofen (10) 24.3 40.1 1.72 1.6
Hexaconazole (15) 23.8 37.6 1.9 1.2
Miconazole (16) 17.5 23.6 1.4 1.6
Methanol:water
30:70
Indoprofen (10) 23.6 63.4 2.8 1.63
Miconazole (16) 17.6 23.6 1.41 1.6
Methanol:water
10:90
Aminoglutethimide (22) 22.4 33.6 1.5 1
Tyrosine (29) 23.4 35 1.5 1.64
O-Methoxymandelic acid (34) 26.1 40.2 1.52 1.1
Methanol:water
10:90, 1%TEA
Acebutolol (4) 22.8 28.7 1.3 1.14
Normetanephrine (21) 22.3 28.4 1.3 1.3
Propafenone (26) 21.4 30.5 1.3 1.2
Tyrosine (29) 18.1 24.2 1.3 1.7
4-Hydroxy-3-methoxymandelic
acid (35) 24.1 31.5 1.3 1.03
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Figure 4. Ena tiosel ctive nano-LC separation of; (a) rac y-3-methoxymandelic acid
(35); (b) phenyla ni e (30) (mobile p ethanol/water 40:60 v/v, ; (c) tyrosine (29) and (d)
O- et lic ci (34) on a 1 capi lary column (150 µm ID, 25 cm length). UV: 219 nm, flow
rate: 1 µL/min.
Becaus of the novelty associ ed with using colistin sulfate as a chiral selector, confirmatory tests
were done by injecting the separated enantiomeric drugs using capillary monolithic column without
chiral selector (blank column, cf. Figure 1). The injected drugs included tyrosine (29), phenylalanine
(30), O-methoxymandelic acid (34) and 4-hydroxy-3-methoxymandelic acid (35). Only single peaks
were obtained under chromatographic conditions similar to those previously used when using capillary
columns with colistin sulfate as CSP (C1 column). Furthermore, the single S-enantiomer of acebutolol
(S-acebutolol) was injected on the C1 column (Figure 2). Only a single peak was obtained when
used alone and mixed with its racemic mixture, which resulted in a peak with higher intensity, but
unfortunately with low resolution. Als it was observed that S-acebutolol eluted first in the same
retention time as the eluted single peak of single isomer S-acebutolol. The results achieved from the
injection of the enantiomers on both the blank and C1 column, confirm the presence of the chiral selector
in situ the capillary d that it was not washed out or dissolved in the mobile phase. The investigated
repeatability of the used C1 column is considered as a proof of stability of the chiral selector contained
in the capillary. It was also observed that the chiral separation was mostly achieved at high water
content in the mobile phase; although, the chiral selector itself can be dissolved in water. This does not
contradict what has been previously reported in literature where similar solvent used for dissolving
the chiral selector can be used as mobile phase in the same column [32].
The combination of thin-hair capillary format in capillary HPLC is also beneficial as swapping
from existing conventional liquid chromatography LC (mL flow, more solvent) to micro/nano flow LC
(less solvent) is beneficial. The expected outcome will be environmentally responsible, cost effective
and efficient analytical sample preparation and separation technologies for analytical laboratories
throughout the world. Some featured benefits include but not limited to: (1) up to 4× increase in
sensitivity; (2) improved turn-around-time with up to 5× faster separations; (3) up to a 95% reduction
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in mobile phase consumption and (4) improved robustness–less sample introduced into the MS when
used in LC/MS and, ultimately, less instrument downtime.
For example, the chiral analysis for one run in conventional HPLC consumes at least 20–30 mL of
environmentally unfriendly solvents for 30 min separation. On the other hand, in nano-HPLC, running
a similar analysis under reversed phase conditions consumes less than 100 µL of water-based mobile
phase. The capillary monolithic column is 10,000 less in internal diameter and operates with one million
times less solvent volume than a conventional column. Consequently, this approach is economically
efficient where only a single sorbent, namely colistin antibiotic, was used as CSP in capillary HPLC
reducing materials/solvents consumption. Taking ibuprofen as an example, it was efficiently separated
on the prepared monolithic column (Rs = 1.02) while it was recently enantio-separated (Rs = 1.05)
on a mixed sorbents containing eremomycin and bovine serum albumin BSA-based CSP under
reversed phase conditions using mobile phase: MeOH:KH2PO4 (0.1 M, pH 4.5); 50:50 (v/v); flow
rate: 0.5 mL/min; and fixed UV 220 nm [34]. Another example is the recent use of mixed chiral
sorbents based on silica with immobilized macrocyclic antibiotics eremomycin and vancomycin for the
enantioselective of β-blockers such as atenolol and amino acids like phenylalanine by conventional
HPLC using a mobile phase of MeOH:ACN–TEAA (0.1%, pH 4.5) (95:5, v/v), and a flow rate of
1 mL/min [37]. Nano-HPLC chromatograms for some of the separated compounds under different
ratios of methanol and water are given in Figure 4.
2.3. Column Repeatability
The repeatability is the ability to prepare equally performing capillaries at different time (run
to run) and locations (batch to batch). To determine the repeatability of the prepared capillaries,
two capillaries were prepared on the same day using the same polymerization mixture to test
column-to-column repeatability. Moreover, batch-to-batch repeatability was tested by preparing three
different batches at different days using the same polymer mixtures. 4-Hydroxy-3-methoxymandelic
acid (35) was selected to test the capillaries’ performance in terms of repeatability as it was
nearly baseline resolved on both columns. Reproducibility of the retention times of both
4-hydroxy-3-methoxymandelic acid (35) peaks was satisfactory. In the run-to-run repeatability using
one column, the average retention times for the two peaks were 23.5 min (RSD = 1.7%) and 30.6 min
(RSD = 1.27%); respectively. In column-to-column repeatability, the average retention times for the two
peaks are 23.5 min (RSD = 2.2%) and 30.6 min (RSD = 1.9%); respectively. In batch-to-batch repeatability,
the average retention times for peak one and peak two are 22.5 min (RSD = 3.9%) and 31.4 min
(RSD = 5.3%); respectively. The retention times and relative standard deviations (RSD) of the retention
times ranged between 1.2% and 5.3%. These results suggest that the monolithic capillary columns can
be used for reproducible routine analysis. It is worth mentioning that the acceptable %RSD values for
intra-batch and inter-batch are 2.5% and 15%; respectively. Furthermore, the column loadability was
tested by injecting more than 300 runs on the same column; 4-hydroxy-3-methoxymandelic acid (35)
was injected in different orders started at run number 160 and ended by run number 307. The same
separation was achieved (Figure 5).
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methanol/ ater 40:60 v/v, V: 219 n , flo rate: 1 µL/min.
2.4. Effect of the Concentration of Chiral Selector
The opti u concentration of the colistin sulfate in the polymerization mixture was selected
after the preparation of three different capillaries ith different concentrations of colistin s lfate (10,
20 and 30 mg/ ). e results revealed that 10 mg/ affor e better separation and resolution
while increasing the concentration to 30 mg/ or ore resulted in poor separation and resolution.
3. Discussion
Various macrocyclic antibiotics have been previously synthesized and applied on silica or polymer
surfaces as a stationary phase either by immobilization, coating or by covalent bonding [24,28,32–36].
Whilst coating or physical adsorption is considered an suitable method to prepare CSPs, covalent
bonding increases the chances for using diverse mobile phases and creates a more robust CSP [46].
It is worth pointing out that most of the CSPs have been prepared via immobilization to bond the
chiral selectors to the solid supports. This has resulted in robust and more stable CSP, however, time
consuming process offering less coverage of the CS compared to the one pot technique [47]. The way
the CSP has been prepared (coating vs. bonding) may affect the chiral recognition mechanism. Thus,
bonded-type phase showed a lower chiral recognition power than the coated-type phase.
Schmid et al. have been reporting since 2006 the development of dynamically-coated chiral
stationary phases [48] using a macrocyclic antibiotic, namely vancomycin. Few macrocyclic antibiotics
were previously used in preparation of chiral monolithic columns for the enantioselective separation of
racemic pharmaceuticals [38]. Of interest, in 2010 Schmid et al. [32] published an article describing the
preparation of a new chiral stationary phase by dynamic coating of a reversed-phase HPLC monolithic
column with vancomycin-derivatives as chiral selector. They then investigated the separation of
amino acids using reversed phase chromatographic conditions, namely triethyl-ammonium acetate
(TEAA) buffer and methanol. As the underivatized vancomycin is hydrophilic, it could not be
adsorbed on the commercial hydrophobic chromolith monolith. Consequently, vancomycin was
derivatized to N-(2-hydroxydodecyl)-derivative before immobilization on the chromolith. Vancomycin
is reversibly adsorbed via a hydrophobic side chain to the reversed-phase material. Similarly, Haroun
et al. [49] dynamically coated the macrocyclic antibiotic teicoplanin on RP18 and RP8 columns.
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Teicoplanin has a hydrophobic C10 side chain which is attached to the glucopyranosyl group (Figure 1).
This side chain was used to immobilize the chiral selector on the hydrophobic reversed phase material.
This dynamically coated phase was used for the separation of aromatic amino acids. Similary, in this
manuscript, colistine possesses a C9 hydrophobic side chain that can be used for the immobilization
on the hydrophobic monolith prepared in this manuscript. It is worth to note that (1) continuous
polymers formed from hydrophobic monomers can be used as stationary phase in reversed phase
chromatography (RPC) and (2). Solvents used for dissolving the chiral sector can be used as mobile
phase (not in excess) on the same column [32].
The chiral recognition of macrocyclic antibiotics used as chiral selectors for the enantio-separation
of different compounds is due to the presentation of ionisable acidic or basic functional groups
contributing to stereoselectivity, the presence of multiple stereogenic centers, and the presence of
both hydrophobic and hydrophilic groups. Therefore, the transient non-covalent diastereomeric
complexes with macrocyclic antibiotic are based on both electrostatic interactions and secondary
interactions such as hydrophobic, hydrogen bonds, dipole-dipole, pi–pi interactions, and steric
repulsion. Macrocyclic antibiotics have been successfully applied to HPLC and also to CEC for
chiral separation of pharmaceutical drugs using stationary phases in the reversed-phase and the
normal-phase modes [50–55].
Colistin sulfate has never been used as chiral selector although it possesses many points of
interaction which significantly increase its enantiorecognition ability. It is well established that
under reversed phase conditions, the formation of inclusion complexes within the cavity is the
most predominant mechanism of retention and enantioselectivity. Moreover, the presence of
different functional groups creates more points of interaction between the enantiomers and the
CSP via pi–pi bonding, hydrogen bonding, dipole–dipole stacking, etc. which can increase the
selectivity towards some analytes. For example, in miconazole (16), hydrophobic interactions are
the prevailing CSP-analyte interactions, whereas hydrogen bonding seems to be more important
in the enantiointeractions between the other analytes and CSPs [32]. Initial testing with mixture
of methanol-based mobile phase, enantioselective separation was observed for many analytes
with polar groups including acebutolol (4), indoprofen (10), hexaconazole (15), normetanephrine
(21), aminoglutethimide (22), propafenone (26), tyrosine (29), O-methoxymandelic acid (34) and
4-hydroxy-3-methoxymandelic acid (35). This confirms the importance of solvent polarity in the chiral
separation mechanism in terms of the inclusion complex stability. The large retention times observed
is due to the very low flow rate used. Higher flow rate may result in high backpressure. Peak tailing
of the more retained isomers was overcome by the use of mobile phase additives such as triethanol-
amine (TEA), which resulted in improved resolution, although, their negative effect on the lifetime of
the capillary columns as well as its potential problems with nano-LC systems (e.g. precipitation in
the pumps and valves) [56] can be dominant. No remarkably peak tailing of acebutolol (4), atenolol
(5) and tyrosine (29) racemates was observed, ascribed to the existence of the amino groups on the
surface of the monolithic matrices. It was also observed that the chiral separation was mostly obtained
at high water content of the mobile phase; this indicates that water facilitates the interaction between
the CSP and the racemates. We postulate that chiral separation in this study was mainly achieved
via the formation of inclusion complexes as discussed previously. The use of normal organic phase
resulted in high back pressure and very short life time of the prepared column. Nevertheless, the use
of n-hexane/2-propanol mobile phase mixture ranging from 10–90% (v/v) resulted in resolution less
than 1.
4. Experimental
4.1. Reagents and Materials
Colistin sulfate (99%), ethylene glycol dimethacrylate (EGDMA, 98%), glycidyl methacrylate
(GMA, 98%), 1-propanol (99%), 1,4-butanediol (99%), trifluoroacetic acid (TFA, ≥99.5%), sodium
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hydroxide and hydrochloric acid were purchased from Sigma Aldrich (Milwaukee, WI, USA). Acetone
(AR grade) and ethanol (HPLC grade) were purchased from BDH (Kilsyth, Vic., Australia). Methanol
(HPLC) grade was purchased from Scharlau (Sentmenat, Spain). All other reagents were of the highest
available grade and used as received. The fused-silica capillaries (150 µm internal diameter) were
purchased from Polymicro Technologies (Phoenix, AZ, USA). 2,2-Azobis(isobutyronitrile) (AIBN)
was obtained from Wako (Osaka, Japan). Water used for dilutions and experiments was purified by
a Nano-pure Infinity water system (NJ, USA). The racemic analytes were mostly purchased from
Sigma Aldrich.
4.2. Preparation and Characterization of the Monolithic Columns
4.2.1. Activation of the Fused Silica Capillaries
Briefly, the fused silica capillaries were rinsed using a Harvard syringe pump (Harvard Apparatus,
Holliston, MA, USA) and a 250 µL gas-tight syringe (Hamilton Company, Reno, NE, USA) with acetone
and water 2–3 times each, activated with 0.2 mol/L sodium hydroxide (NaOH) for 6 h confirming
the absence of any air bubbles, washed with water 3–4 times till neutral (pH 7), then washed with
0.2 mol/L hydrochloride (HCl) for 12 h, rinsed with water and ethanol 2–3 times each. A 20% (w/w)
solution of 3-(trimethoxysilyl)propyl methacrylate in 95% ethanol adjusted to pH 5 using acetic acid
was pumped through the capillaries at a flow rate of 0.25 µL/min for 6 h. The capillary was then
washed with acetone one time and dried with a stream of nitrogen for 2 min. then left at room
temperature for 24 h.
4.2.2. Preparation of Colistin Sulfate Functionalized Monomer
The short (∼25 cm in length) surface modified capillary was filled by Harvard syringe pump
with the degassed polymerization mixture at 0.25 µL/min using the syringe pump. Colistin sulfate
polymer-based monolithic capillary column was prepared via in situ copolymerization of binary
monomer mixtures consisted of GMA (20%) as a monomer and EGDMA (20%) as across linker along
with different porogens namely; 1-propanol (48%), 1,4-butanediol (6%), in the presence of 1 wt% AIBN
(with respect to monomers) and colistin sulfate (6%) as chiral selector. The blank column (G column)
was prepared using the same procedure by addition of water (6%) instead of water. The filled capillaries
were then sealed with a septum, placed in 70 ◦C water bath for 18 h for the polymerization reaction
to take place. The unreacted monomers were removed from the monolithic columns by pumping
methanol at a flow rate of 100 µL/h for 24 h before being investigated under light microscope to
ensure its consistency and homogeneity of the polymerization mixture inside the capillary. The filled
capillaries were conditioned with mobile phase for 1–3 days at µL/min (Figure 6). The ratios of the
monomers to the porogens were kept 40% and 60%, respectively. The ratios of the porogens were fixed
as 48% 1-propanol, 6% 1,4-butanediol and 6% chiral selector, all percentages are w/w.
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4.2.3. SEM of the Prepared Monoliths
SEM was performed to study the morphology of the prepared capillaries. The capillaries were
cut into ~1 cm sections and put perpendicularly on 12.7 mm pin-type aluminum stub using double
face epoxy resin tape. SEM was carried out and high resolution images were collected by sputter
coating the capillary sections with gold Using ZEISS SIGMA FE-SEMs for High Quality Imaging and
Advanced Analytical Microscopy (ZEISS Sigma, Jena, Germany).
4.3. Instrumentation
A nano-liquid chromatographic system consisting of an LC-10AD VP pump (Shimadzu, Kyoto,
Japan), injector model 7725i-049 (Rheodyne, Park Court, CA, USA), a UV-Vis detector model MU 701
UV-VIS (GL Science, Tokyo, Japan) and a Shimadzu CDM-20A communications bus module was used.
The system flow was split after direct injection. The data was processed by the Shimadzu Lab-Solutions
software version 5.54 SP2 (Shimadzu, Kyoto, Japan).
4.4. Standard Solutions and Sample Preparation
Stock solutions of the racemic analytes at concentrations of 1 mg/mL in filtered HPLC grade
methanol were prepared. Prior to injection, the stock solutions were further diluted 10× by mobile
phase and filtered through Minisart RC 15 0.2 µm pore size filters (Sartorius, Goettingen, Germany).
Tested compounds: β-blockers: alprenolol (1), metoprolol (2), propranolol (3), acebutolol (4), atenolol
(5); α-blockers: naftopidil (6); anti-inflammatory drugs: ibuprofen (7), naproxen (8), flurbiprofen (9),
indoprofen (10), cizolirtine (11), cizolirtine citrate (12), carprofen (13), glafenine (14); antifungal drugs:
hexaconazole (15), miconazole (16), diniconazole (17) sulconazole (18); norepinephrine-dopamine
reuptake inhibitor: nomifensine (19); catecholamines: arterenol (20), normetanephrine (21); sedative
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hypnotics: aminoglutethimide (22); anti-histamines: chlorpheneramine (23); anticancer drugs:
ifosfamide (24); antiarrhythmic drugs: tocainide (25), propafenone (26); flavonoids: flavanone (27);
amino acids: glutamic acid monohydrate (28), tyrosine (29), phenylalanine (30); anti-platelet agents:
clopidogrel (31); immunomodulatory drugs: thalidomide (32); miscellaneous: 1-acenaphthenol (33),
O-methoxymandelic acid (34) 4-hydroxy-3-methoxymandelic acid (35), 1-indanol (36) and ampicillin
(37). The chemical structures of the investigated racemates are shown in Figure 3.
4.5. HPLC Conditions
The mobile phase consisted of water/methanol (v/v) for the reversed phase HPLC and
n-hexane/2-propanol for normal phase HPLC. For all samples, the injected volume was 0.2 µL at room
temperature with flow rate 1 µL/min on C1 capillary column (150 µm ID, 25 cm length). Preliminary
UV analyses were performed at a wavelength of 219 nm.
5. Conclusions
The macrocyclic antibiotic colistin sulphate has been used for the first time as a chiral selector
entrapped in a polymer monolith for enantioselective capillary chromatography. The new capillary
column was investigated for the enantioselective separation of a set of racemic drugs. Acceptable
separation was achieved for many drugs, including acebutolol (4), ibuprofen (7), indoprofen (10),
hexaconazole (15), miconazole (16), normetanephrine (21), aminoglutethimide (22), propafenone
(26), tyrosine (29), O-methoxymandelic acid (34) and 4-hydroxy-3-methoxymandelic acid (35) under
reversed phase chromatographic conditions, while normal phase conditions did not achieve any
acceptable separations. The method provides more economical analysis under environmentally benign
reversed phase conditions.
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